MEAI is a non-hallucinergic psychedelic with chemical structure similar to MDMA.
In this review from our lab, we discussed the potential Therapeutic use if MEAI in the treatment of alcohol use disorder (AUD).
#psychedelics#MDMA#MEAI@YaleABNLab@YalePsych
We will discuss findings and lessons learned from our ongoing first-in-human clinical trial of MEAI in healthy participants and individuals with alcohol use disorder.
@YaleABNLab@YalePsych
Our team is currently seeking adults who heavily drink alcohol, ages 21 to 65, for a psychedelic clinical trial. Participants are eligible for compensation up to $1,650. If interested, please call us back at 203-932-5711 x1-5314 or 203-974-7324!
Our team is currently seeking adults who heavily drink alcohol, ages 21 to 65, for a psychedelic clinical trial. Participants are eligible for compensation up to $1,675. If interested, please call us back at 203-932-5711 x1-5314 or 203-974-7324
Our team is currently seeking healthy volunteers age 18-60 for a psychedelic clinical trial located in New Haven, CT. Participants are eligible for compensation up to $625. If interested, please call us back at 203-974-7324!